Related Experiment Video
Updated: Dec 9, 2025

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
Published on: October 27, 2023
Comorbidity management in spondyloarthritis
Clementina López-Medina1,2,3,4, Anna Molto5,2
1Rheumatology Department, Hôpital Cochin - APHP Centre, Paris, France anna.molto@aphp.fr.
Comorbidities significantly impact spondyloarthritis (SpA) patients, affecting quality of life and increasing costs. This review updates management strategies for common SpA comorbidities like osteoporosis and cardiovascular disease.
Area of Science:
- Rheumatology
- Internal Medicine
Background:
- Comorbidities are common in spondyloarthritis (SpA), negatively impacting patient outcomes, mortality, and healthcare expenses.
- Effective screening and management strategies are crucial for improving the quality of life for SpA patients.
Purpose of the Study:
- To provide an updated review of prevalent comorbidities in spondyloarthritis (SpA).
- To discuss the latest evidence regarding the management of these comorbidities in SpA patients.
Main Methods:
- Literature review of recent studies and clinical trials.
- Analysis of data on the incidence and impact of various comorbidities in SpA.
Main Results:
- Osteoporosis is the most common comorbidity in SpA, linked to inflammation and immobility.
- Cardiovascular diseases contribute to increased mortality in SpA patients.
- Infections and malignant diseases show low incidence; fibromyalgia negatively affects treatment response.
Conclusions:
- Managing comorbidities is essential for improving outcomes in spondyloarthritis.
- Specific comorbidities like osteoporosis, cardiovascular disease, and fibromyalgia require targeted interventions.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Atherosclerosis III: Management
Rheumatic Heart Disease IV: Nursing Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Atherosclerosis IV: Nursing Management

